Harbor Investment Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Buy
10,157
+278
+3% +$284K 0.85% 20
2026
Q1
$9.09M Sell
9,879
-169
-2% -$171K 0.72% 23
2025
Q4
$10.8M Buy
10,048
+155
+2% +$148K 0.81% 21
2025
Q3
$7.55M Sell
9,893
-220
-2% -$164K 0.62% 27
2025
Q2
$7.88M Sell
10,113
-9
-0.1% -$6.99K 0.7% 24
2025
Q1
$8.36M Sell
10,122
-574
-5% -$478K 0.81% 20
2024
Q4
$8.26M Buy
10,696
+546
+5% +$452K 0.77% 20
2024
Q3
$8.99M Sell
10,150
-250
-2% -$225K 0.89% 18
2024
Q2
$9.42M Buy
10,400
+55
+0.5% +$44K 0.98% 16
2024
Q1
$8.05M Buy
10,345
+421
+4% +$300K 0.84% 18
2023
Q4
$5.79M Buy
9,924
+193
+2% +$113K 0.67% 25
2023
Q3
$5.23M Buy
9,731
+340
+4% +$175K 0.68% 23
2023
Q2
$4.4M Sell
9,391
-169
-2% -$70.9K 0.61% 30
2023
Q1
$3.28M Buy
9,560
+766
+9% +$258K 0.49% 45
2022
Q4
$3.22M Sell
8,794
-67
-0.8% -$23.8K 0.5% 46
2022
Q3
$2.87M Sell
8,861
-397
-4% -$126K 0.47% 45
2022
Q2
$3M Sell
9,258
-13
-0.1% -$3.9K 0.48% 45
2022
Q1
$2.65M Buy
9,271
+62
+0.7% +$16K 0.35% 57
2021
Q4
$2.54M Sell
9,209
-272
-3% -$69K 0.32% 59
2021
Q3
$2.19M Sell
9,481
-168
-2% -$41.5K 0.3% 67
2021
Q2
$2.21M Buy
9,649
+2,351
+32% +$472K 0.3% 72
2021
Q1
$1.36M Buy
7,298
+232
+3% +$45.4K 0.21% 104
2020
Q4
$1.19M Buy
7,066
+4,131
+141% +$617K 0.19% 104
2020
Q3
$434K Buy
2,935
+1,295
+79% +$200K 0.08% 177
2020
Q2
$269K Buy
1,640
+107
+7% +$16.4K 0.06% 224
2020
Q1
$213K Hold
1,533
0.06% 225
2019
Q4
$201K Buy
+1,533
New +$178K 0.05% 246

Other funds holding LLY

Harbor Investment Advisory's LLY Position: Q2 2026 in Review

Harbor Investment Advisory increased its Eli Lilly (LLY) stake by 2.8% in Q2 2026, buying an estimated $284K and bringing the position to 10,157 shares worth $12.2M. The position accounts for 0.85% of the portfolio, ranked #20.

Harbor Investment Advisory first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harbor Investment Advisory held 10,157 shares of Eli Lilly worth $12.2M as of Q2 2026.
  • Harbor Investment Advisory bought 278 Eli Lilly shares in Q2 2026, an estimated $284K.
  • Eli Lilly made up 0.85% of Harbor Investment Advisory's portfolio in Q2 2026, its #20 holding.
  • Harbor Investment Advisory first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.